This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Vivozon, Inc.. Active years: 2024-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2025
Title: Innovations and Contributions of Inventor Dae Kyu Choi
Introduction: Dae Kyu Choi is a prominent inventor based in Yongin-si, South Korea, recognized for his innovative contributions to the field of pharmacology. His work primarily focuses on the development of novel therapeutic agents.
Latest Patents: Choi holds a patent for a groundbreaking invention titled "Dual Modulator of mGluR5 and 5-HT2A Receptor, and Use Thereof." This patent discloses a dual modulator that operates simultaneously on mGluR5 and serves as an antagonist for the 5-HT2A receptor. The compound is aimed at providing therapeutic effects for pain management.
Career Highlights: As an inventor at Vivozon, Inc., Dae Kyu Choi has made significant strides in the pharmaceutical industry. His innovative approach to drug development has positioned him as a key player in creating solutions for complex health issues.
Collaborations: Choi collaborates closely with his talented coworkers, including Hyo Jin Kim and Mi Seon Bae, contributing to a dynamic and innovative environment at Vivozon, Inc. Their collective efforts enhance the research and development process, aiming to bring effective therapies to market.
Conclusion: Dae Kyu Choi's contributions to the field of pharmacology through his patent on dual modulation of receptors highlight his role as a forward-thinking inventor. His ongoing work at Vivozon, Inc. will likely lead to further advancements in therapeutic agents and the overall improvement of patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile